Global Oncology Biosimilars Market Insights: Impact of COVID-19 and Future Expectations to 2028

Publisher Name :
Date: 18-May-2023
No. of pages: 123

Oncology Biosimilars are kind of Biosimilars. A biosimilar product is a biologic agent that is highly similar to an already-approved biological compound, known as the reference or originator product, and approved for use in the same indications as the reference product

The Oncology Biosimilars market revenue was 3391.63 Million USD in 2022, and will reach 7549.15 Million USD in 2028, with a CAGR of 14.27% during 2022-2028.

This report elaborates the market size, market characteristics, and market growth of the Oncology Biosimilars industry, and breaks down according to the type, application, and consumption area of Oncology Biosimilars. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Oncology Biosimilars in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the global Oncology Biosimilars market covered in Chapter 11:

Celltrion Inc.

Dr. Reddy's Laboratories

F Hoffmann-La Roche

Mylan

Teva Pharmaceutical Industries Ltd.

STADA Arzneimittel AG

Pfizer Inc.

Intas Pharmaceuticals Ltd.

BIOCAD

Biocon

Sandoz International GmbH

Apotex Inc.

In Chapter 3, on the basis of types, the Oncology Biosimilars market from 2018 to 2028 is primarily split into:

G-CSF

Hematopoietic Agents

Monoclonal Antibodies

In Chapter 4, on the basis of applications, the Oncology Biosimilars market from 2018 to 2028 covers:

Retail pharmacies

Hospital pharmacies

Online pharmacies

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:

North America (Covered in Chapter 6)

United States

Canada

Mexico

Europe (Covered in Chapter 7)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8)

China

Japan

South Korea

Australia

India

Middle East and Africa (Covered in Chapter 9)

Saudi Arabia

UAE

Egypt

South Africa

South America (Covered in Chapter 10)

Brazil

Argentina

Columbia

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Oncology Biosimilars Market Insights: Impact of COVID-19 and Future Expectations to 2028

Table of Content

1 Report Overview
1.1 Research Objectives
1.2 Study Scope
1.3 Key Market Segments
1.4 Market Investment Scenario Strategic

2 Industry Insights
2.1 Industry Ecosystem Analysis
2.1.1 Industry Chain Analysis
2.1.2 Distribution Channel Analysis
2.2 Market Trend Analysis
2.2.1 Growth Drivers
2.2.2 Industry Constraints and Challenges
2.3 Industry Trends Under COVID-19
2.3.1 Risk Assessment on COVID-19
2.3.2 Assessment of the Overall Impact of COVID-19 on the Industry
2.3.3 Pre COVID-19 and Post COVID-19 Market Scenario
2.4 Industry Innovation Prospect Analysis
2.5 The Impact of Covid-19 From the Perspective of Industry Chain

3 Global Oncology Biosimilars Market, By Product Type
3.1 Global Oncology Biosimilars Sales, Revenue and Market Share by Types (2018-2023)
3.1.1 Global Oncology Biosimilars Sales and Market Share by Types (2018-2023)
3.1.2 Global Oncology Biosimilars Revenue and Market Share by Types (2018-2023)
3.1.3 Global Oncology Biosimilars Price by Types (2018-2023)
3.2 Key Trends by Types
3.3 Global Oncology Biosimilars Sales, Price and Growth Rate of G-CSF (2018-2023)
3.4 Global Oncology Biosimilars Sales, Price and Growth Rate of Hematopoietic Agents (2018-2023)
3.5 Global Oncology Biosimilars Sales, Price and Growth Rate of Monoclonal Antibodies (2018-2023)

4 Global Oncology Biosimilars Market, By Applications
4.1 Global Oncology Biosimilars Consumption, Revenue and Market Share by Applications (2018-2023)
4.1.1 Global Oncology Biosimilars Consumption and Market Share by Applications (2018-2023)
4.1.2 Global Oncology Biosimilars Revenue and Market Share by Applications (2018-2023)
4.2 Retail pharmacies
4.3 Hospital pharmacies
4.4 Online pharmacies

5 Global Oncology Biosimilars Market, By Regions
5.1 Global Oncology Biosimilars Market Sales and Market Share by Regions
5.1.1 Global Oncology Biosimilars Sales by Regions (2018-2023)
5.1.2 Global Oncology Biosimilars Sales Market Share by Regions (2018-2023)
5.2 Global Oncology Biosimilars Market Revenue and Market Share by Regions
5.2.1 Global Oncology Biosimilars Revenue by Regions (2018-2023)
5.2.2 Global Oncology Biosimilars Revenue Market Share by Regions (2018-2023)
5.3 Key Trends by Regions
5.3.1 Emerging Market Analysis

6 North America Oncology Biosimilars Market Analysis
6.1 North America Oncology Biosimilars Market Size
6.1.1 North America Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
6.1.2 North America Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
6.2 U.S. Oncology Biosimilars Market Size
6.3 Canada Oncology Biosimilars Market Size
6.4 Mexico Oncology Biosimilars Market Size
6.5 Key Macroeconomic Indicators
6.6 The Influence of COVID-19 on North America Market

7 Europe Oncology Biosimilars Market Analysis
7.1 Europe Oncology Biosimilars Market Size
7.1.1 Europe Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
7.1.2 Europe Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
7.2 Germany Oncology Biosimilars Market Size
7.3 United Kingdom Oncology Biosimilars Market Size
7.4 France Oncology Biosimilars Market Size
7.5 Italy Oncology Biosimilars Market Size
7.6 Spain Oncology Biosimilars Market Size
7.7 Russia Oncology Biosimilars Market Size
7.8 Key Macroeconomic Indicators
7.9 The Influence of COVID-19 on Europe Market

8 Asia-Pacific Oncology Biosimilars Market Analysis
8.1 Asia-Pacific Oncology Biosimilars Market Size
8.1.1 Asia-Pacific Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
8.1.2 Asia-Pacific Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
8.2 China Oncology Biosimilars Market Size
8.3 Japan Oncology Biosimilars Market Size
8.4 South Korea Oncology Biosimilars Market Size
8.5 Australia Oncology Biosimilars Market Size
8.6 India Oncology Biosimilars Market Size
8.7 Key Macroeconomic Indicators
8.8 The Influence of COVID-19 on Asia Pacific Market

9 Middle East and Africa Oncology Biosimilars Market Analysis
9.1 Middle East and Africa Oncology Biosimilars Market Size
9.1.1 Middle East and Africa Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
9.1.2 Middle East and Africa Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
9.2 Saudi Arabia Oncology Biosimilars Market Size
9.3 UAE Oncology Biosimilars Market Size
9.4 Egypt Oncology Biosimilars Market Size
9.5 South Africa Oncology Biosimilars Market Size
9.6 Key Macroeconomic Indicators
9.7 The Influence of COVID-19 on Middle East and Africa Market

10 South America Oncology Biosimilars Market Analysis
10.1 South America Oncology Biosimilars Market Size
10.1.1 South America Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
10.1.2 South America Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
10.2 Brazil Oncology Biosimilars Market Size
10.3 Argentina Oncology Biosimilars Market Size
10.4 Columbia Oncology Biosimilars Market Size
10.5 Key Macroeconomic Indicators
10.6 The Influence of COVID-19 on South America Market

11 Competition Landscape and Company Profiles
11.1 Celltrion Inc.
11.1.1 Celltrion Inc. Basic Information
11.1.2 Celltrion Inc. Product Profiles, Application and Specification
11.1.3 Celltrion Inc. Oncology Biosimilars Market Performance (2018-2023)
11.2 Dr. Reddy's Laboratories
11.2.1 Dr. Reddy's Laboratories Basic Information
11.2.2 Dr. Reddy's Laboratories Product Profiles, Application and Specification
11.2.3 Dr. Reddy's Laboratories Oncology Biosimilars Market Performance (2018-2023)
11.3 F Hoffmann-La Roche
11.3.1 F Hoffmann-La Roche Basic Information
11.3.2 F Hoffmann-La Roche Product Profiles, Application and Specification
11.3.3 F Hoffmann-La Roche Oncology Biosimilars Market Performance (2018-2023)
11.4 Mylan
11.4.1 Mylan Basic Information
11.4.2 Mylan Product Profiles, Application and Specification
11.4.3 Mylan Oncology Biosimilars Market Performance (2018-2023)
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Basic Information
11.5.2 Teva Pharmaceutical Industries Ltd. Product Profiles, Application and Specification
11.5.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Market Performance (2018-2023)
11.6 STADA Arzneimittel AG
11.6.1 STADA Arzneimittel AG Basic Information
11.6.2 STADA Arzneimittel AG Product Profiles, Application and Specification
11.6.3 STADA Arzneimittel AG Oncology Biosimilars Market Performance (2018-2023)
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Basic Information
11.7.2 Pfizer Inc. Product Profiles, Application and Specification
11.7.3 Pfizer Inc. Oncology Biosimilars Market Performance (2018-2023)
11.8 Intas Pharmaceuticals Ltd.
11.8.1 Intas Pharmaceuticals Ltd. Basic Information
11.8.2 Intas Pharmaceuticals Ltd. Product Profiles, Application and Specification
11.8.3 Intas Pharmaceuticals Ltd. Oncology Biosimilars Market Performance (2018-2023)
11.9 BIOCAD
11.9.1 BIOCAD Basic Information
11.9.2 BIOCAD Product Profiles, Application and Specification
11.9.3 BIOCAD Oncology Biosimilars Market Performance (2018-2023)
11.10 Biocon
11.10.1 Biocon Basic Information
11.10.2 Biocon Product Profiles, Application and Specification
11.10.3 Biocon Oncology Biosimilars Market Performance (2018-2023)
11.11 Sandoz International GmbH
11.11.1 Sandoz International GmbH Basic Information
11.11.2 Sandoz International GmbH Product Profiles, Application and Specification
11.11.3 Sandoz International GmbH Oncology Biosimilars Market Performance (2018-2023)
11.12 Apotex Inc.
11.12.1 Apotex Inc. Basic Information
11.12.2 Apotex Inc. Product Profiles, Application and Specification
11.12.3 Apotex Inc. Oncology Biosimilars Market Performance (2018-2023)

12 Global Oncology Biosimilars Market Forecast, By Type and Applications
12.1 Global Oncology Biosimilars Market Forecast by Types (2023-2028)
12.1.1 Global Oncology Biosimilars Market Forecast Sales and Market Share by Types (2023-2028)
12.1.2 Global Oncology Biosimilars Market Forecast Revenue and Market Share by Types (2023-2028)
12.2 Global Oncology Biosimilars Market Forecast by Applications (2023-2028)
12.2.1 Global Oncology Biosimilars Market Forecast Consumption and Market Share by Applications (2023-2028)
12.2.2 Global Oncology Biosimilars Market Forecast Revenue and Market Share by Applications (2023-2028)

13 Global Oncology Biosimilars Market Forecast, By Regions
13.1 Global Oncology Biosimilars Market Forecast Sales and Market Share by Regions (2023-2028)
13.2 Global Oncology Biosimilars Market Forecast Revenue and Market Share by Regions (2023-2028)
13.3 North America Oncology Biosimilars Market Forecast (2023-2028)
13.4 Europe Oncology Biosimilars Market Forecast (2023-2028)
13.5 Asia-Pacific Oncology Biosimilars Market Forecast (2023-2028)
13.6 Middle East and Africa Oncology Biosimilars Market Forecast (2023-2028)
13.7 South America Oncology Biosimilars Market Forecast (2023-2028)

14 Appendix
14.1 Methodology
14.2 Research Data Source
14.2.1 Secondary Data
14.2.2 Primary Data
14.2.3 Market Size Estimation
14.2.4 Legal Disclaimer

List of Tables and Figures

Table Oncology Biosimilars Key Market Segments
Figure Global Oncology Biosimilars Market Size and Growth Rate 2018-2028
Figure Channel Status of Oncology Biosimilars
Table Market Driving Factors of Oncology Biosimilars
Table Market Industry Constraints and Challenges of Oncology Biosimilars
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Table Global Oncology Biosimilars Sales by Types (2018-2023)
Table Global Oncology Biosimilars Sales Share by Types (2018-2023)
Table Global Oncology Biosimilars Revenue ($) by Types (2018-2023)
Table Global Oncology Biosimilars Revenue Share by Types (2018-2023)
Table Global Oncology Biosimilars Price by Types (2018-2023)
Figure Global G-CSF Sales and Growth Rate (2018-2023)
Figure Global G-CSF Price (2018-2023)
Figure Global Hematopoietic Agents Sales and Growth Rate (2018-2023)
Figure Global Hematopoietic Agents Price (2018-2023)
Figure Global Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Global Monoclonal Antibodies Price (2018-2023)
Table Global Oncology Biosimilars Consumption by Applications (2018-2023)
Table Global Oncology Biosimilars Consumption Share by Applications (2018-2023)
Table Global Oncology Biosimilars Revenue ($) by Applications (2018-2023)
Table Global Oncology Biosimilars Revenue Share by Applications (2018-2023)
Figure Global Retail pharmacies Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Hospital pharmacies Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Online pharmacies Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Oncology Biosimilars Sales and Growth Rate (2018-2023)
Table Global Oncology Biosimilars Sales by Regions (2018-2023)
Table Global Oncology Biosimilars Sales Market Share by Regions (2018-2023)
Figure Global Oncology Biosimilars Sales Market Share by Regions in 2022
Figure Global Oncology Biosimilars Revenue and Growth Rate (2018-2023)
Table Global Oncology Biosimilars Revenue by Regions (2018-2023)
Table Global Oncology Biosimilars Revenue Market Share by Regions (2018-2023)
Figure Global Oncology Biosimilars Revenue Market Share by Regions in 2022
Figure North America Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Table North America Oncology Biosimilars Sales by Countries (2018-2023)
Figure North America Oncology Biosimilars Market Revenue ($) and Growth Rate (2018-2023)
Table North America Oncology Biosimilars Revenue ($) by Countries (2018-2023)
Figure U.S. Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure U.S. Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Canada Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Canada Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Mexico Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Mexico Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure North America COVID-19 Status
Figure Europe Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Table Europe Oncology Biosimilars Sales by Countries (2018-2023)
Figure Europe Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Table Europe Oncology Biosimilars Revenue by Countries (2018-2023)
Figure Germany Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Germany Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure United Kingdom Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure United Kingdom Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure France Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure France Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Italy Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Italy Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Spain Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Spain Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Russia Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Russia Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Europe COVID-19 Status
Figure Asia-Pacific Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Table Asia-Pacific Oncology Biosimilars Sales by Countries (2018-2023)
Figure Asia-Pacific Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Table Asia-Pacific Oncology Biosimilars Revenue by Countries (2018-2023)
Figure China Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure China Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Japan Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Japan Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure South Korea Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure South Korea Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Australia Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Australia Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure India Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure India Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Table Middle East and Africa Oncology Biosimilars Sales by Countries (2018-2023)
Figure Middle East and Africa Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Oncology Biosimilars Revenue by Countries (2018-2023)
Figure Saudi Arabia Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure UAE Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure UAE Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Egypt Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Egypt Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure South Africa Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure South Africa Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure South America Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Table South America Oncology Biosimilars Sales by Countries (2018-2023)
Figure South America Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Table South America Oncology Biosimilars Revenue by Countries (2018-2023)
Figure Brazil Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Brazil Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Argentina Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Argentina Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Figure Columbia Oncology Biosimilars Market Sales and Growth Rate (2018-2023)
Figure Columbia Oncology Biosimilars Market Revenue and Growth Rate (2018-2023)
Table Celltrion Inc. Company Profile
Table Celltrion Inc. Production, Value, Price, Gross Margin 2018-2023
Figure Celltrion Inc. Production and Growth Rate
Figure Celltrion Inc. Value ($) Market Share 2018-2023
Table Dr. Reddy's Laboratories Company Profile
Table Dr. Reddy's Laboratories Production, Value, Price, Gross Margin 2018-2023
Figure Dr. Reddy's Laboratories Production and Growth Rate
Figure Dr. Reddy's Laboratories Value ($) Market Share 2018-2023
Table F Hoffmann-La Roche Company Profile
Table F Hoffmann-La Roche Production, Value, Price, Gross Margin 2018-2023
Figure F Hoffmann-La Roche Production and Growth Rate
Figure F Hoffmann-La Roche Value ($) Market Share 2018-2023
Table Mylan Company Profile
Table Mylan Production, Value, Price, Gross Margin 2018-2023
Figure Mylan Production and Growth Rate
Figure Mylan Value ($) Market Share 2018-2023
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2018-2023
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2018-2023
Table STADA Arzneimittel AG Company Profile
Table STADA Arzneimittel AG Production, Value, Price, Gross Margin 2018-2023
Figure STADA Arzneimittel AG Production and Growth Rate
Figure STADA Arzneimittel AG Value ($) Market Share 2018-2023
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Production, Value, Price, Gross Margin 2018-2023
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2018-2023
Table Intas Pharmaceuticals Ltd. Company Profile
Table Intas Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2018-2023
Figure Intas Pharmaceuticals Ltd. Production and Growth Rate
Figure Intas Pharmaceuticals Ltd. Value ($) Market Share 2018-2023
Table BIOCAD Company Profile
Table BIOCAD Production, Value, Price, Gross Margin 2018-2023
Figure BIOCAD Production and Growth Rate
Figure BIOCAD Value ($) Market Share 2018-2023
Table Biocon Company Profile
Table Biocon Production, Value, Price, Gross Margin 2018-2023
Figure Biocon Production and Growth Rate
Figure Biocon Value ($) Market Share 2018-2023
Table Sandoz International GmbH Company Profile
Table Sandoz International GmbH Production, Value, Price, Gross Margin 2018-2023
Figure Sandoz International GmbH Production and Growth Rate
Figure Sandoz International GmbH Value ($) Market Share 2018-2023
Table Apotex Inc. Company Profile
Table Apotex Inc. Production, Value, Price, Gross Margin 2018-2023
Figure Apotex Inc. Production and Growth Rate
Figure Apotex Inc. Value ($) Market Share 2018-2023
Table Global Oncology Biosimilars Market Forecast Sales by Types (2023-2028)
Table Global Oncology Biosimilars Market Forecast Sales Share by Types (2023-2028)
Table Global Oncology Biosimilars Market Forecast Revenue ($) by Types (2023-2028)
Table Global Oncology Biosimilars Market Forecast Revenue Share by Types (2023-2028)
Table Global Oncology Biosimilars Market Forecast Consumption by Applications (2023-2028)
Table Global Oncology Biosimilars Market Forecast Consumption Share by Applications (2023-2028)
Table Global Oncology Biosimilars Market Forecast Revenue ($) by Applications (2023-2028)
Table Global Oncology Biosimilars Market Forecast Revenue Share by Applications (2023-2028)
Table Global Oncology Biosimilars Market Forecast Sales by Regions (2023-2028)
Table Global Oncology Biosimilars Market Forecast Sales Share by Regions (2023-2028)
Table Global Oncology Biosimilars Market Forecast Revenue ($) by Regions (2023-2028)
Table Global Oncology Biosimilars Market Forecast Revenue Share by Regions (2023-2028)
Figure North America Market Sales and Growth Rate Forecast (2023-2028)
Figure North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Europe Market Sales and Growth Rate Forecast (2023-2028)
Figure Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Sales and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Sales and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure South America Market Sales and Growth Rate Forecast (2023-2028)
Figure South America Market Revenue ($) and Growth Rate Forecast (2023-2028)
  • Global Biosimilar Monoclonal Antibodies Market Insights, Forecast to 2029
    Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 88
    Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufacture......
  • Global Biologics and Biosimilars Market Insights, Forecast to 2029
    Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 115
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactu......
  • Global Biologics and Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Sep-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Biologics and Biosimilars market: According to our latest research, the global Biologics and Biosimilars market looks promising in the next 5 years. As of 2022, the global Biologics and Biosimilars market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Biosimilars are biomedical products that are almost identical to the original products made by different companies. ......
  • Global Biosimilar Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Aug-2023        Price: US 3260 Onwards        Pages: 125
    Biosimilar therapy is defined as a therapy that is highly similar to approved biopharmaceuticals. They are made by converting biopharmaceuticals made from living cells in the laboratory into large-scale production molecules. This is quite different from the general treatment method, which is identical to the reference small molecule drug. The reason behind this is that it is impossible to make a copy of the same biologic drug. The Biosimilar Drug market revenue was 16199.84 Million USD in......
  • Global Oncology Biosimilars Market Insights, Forecast to 2029
    Published: 07-Jul-2023        Price: US 4900 Onwards        Pages: 110
    Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry......
  • Global Adalimumab Biosimilar Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 04-Jul-2023        Price: US 3260 Onwards        Pages: 125
    Adalimumab was a first fully humanized monoclonal antibody approved by US Food and Drug Administration (FDA) in 2002. Clinical efficacy and safety of adalimumab has been assessed in various trials in rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. It is one of the major sales success among biological and still one of the greatest blockbuster amongst monoclonal antibodies. The Adalimumab Biosimilar market revenue was 2......
  • Global Follow-On-Biologics Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 114
    The Follow-On-Biologics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Follow-On-Biologics industry, and breaks down according to the type, application, and consumption area of Follow-On-Biologics. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......
  • Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region - Global Forecast to 2028
    Published: 15-Jun-2023        Price: US 4950 Onwards        Pages: 306
    “The biosimilars market is projected to grow at a CAGR of 17.8% during the forecast of 2023-2028” The global biosimilars market size is projected to reach USD 66.9 billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% during the forecast period. Factors such as regulatory approvals, favorable reimbursement policies, rising demand for cost effective biosimilars is driving the market growth. “The monoclonal antibodies produc......
  • Global Biosimilars-On-Biologics Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 06-Jun-2023        Price: US 3260 Onwards        Pages: 130
    The Biosimilars-On-Biologics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Biosimilars-On-Biologics industry, and breaks down according to the type, application, and consumption area of Biosimilars-On-Biologics. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs